Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • TF_Legit.Health_Plus
    • Legit.Health Plus TF index
    • Legit.Health Plus STED
    • Legit.Health Plus description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
      • Evaluation
      • Investigation
        • 🗄 Drafts
        • BI 2024
        • COVIDX EVCDAO 2022
        • DAO Derivación O 2022
        • DAO Derivación PH 2022
        • IDEI 2023
        • MC EVCDAO 2019
        • PH 2024
        • SAN 2024
      • R-TF-015-008 Clinical development plan_2023_002
    • Design and development
    • Design History File (DHF)
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
  • Licenses and accreditations
  • External documentation
  • TF_Legit.Health_Plus
  • Clinical
  • Investigation

Investigation

🗃️ 🗄 Drafts

4 items

🗃️ BI 2024

2 items

🗃️ COVIDX EVCDAO 2022

2 items

🗃️ DAO Derivación O 2022

2 items

🗃️ DAO Derivación PH 2022

2 items

🗃️ IDEI 2023

2 items

🗃️ MC EVCDAO 2019

2 items

🗃️ PH 2024

2 items

🗃️ SAN 2024

2 items

Previous
R-TF-015-007 Delaration of interest Clinical evaluation team 2023_006
Next
🗄 Drafts
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)